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Abstract: Five indole alkaloids, corynantheidine, corynan-
theine, dihydrocorynantheine, a-yohimbine and corynanthine
were isolated from bark of Corynanthe pachyceras K. Schum.
(Rubiaceae). The structures were established by spectroscopic
methods, inlcuding previously unreported assignment of all
1
H-
NMR resonances by COSY and NOESY experiments. These and
related alkaloids showed pronounced activity against Leishma-
nia major promastigotes (IC
50
at the micromolar level) but no
significant in vitro antiplasmodial activity (against chloroquine-
sensitive Plasmodium falciparum). Cytotoxicity assessed with
drug sensitive KB-3-1 and multidrug-resistant KB-V1 cell lines
was low; the alkaloids are apparently not substrates for the P-
glycoprotein (P-170) efflux pump.
Key words: Indole alkaloids, Plasmodium, Leishmania, multi-
drug resistance, NMR.
Introduction
Corynanthe pachyceras K. Schum. [syn. Pausinystalia pachyce-
ras (K. Schum.) De Wild., Pseudocinchona pachyceras (K.
Schum.) A. Chev., Pseudocinchona africana A. Chev.] is a lower
storey forest tree growing in tropical West Africa. In Ghana,
the plant is used as intoxicant, local anaesthetic, and a febri-
fuge (1). This and related Rubiaceae species, such as C. jo-
himbe K. Schum., are the classical sources of indole alkaloids
of the yohimbine- and corynantheine-type. In a screening
program for antimalarial and leishmanicidal plants conducted
at this laboratory, crude extracts of bark of C. pachyceras ex-
hibited a high activity. Isolation and characterization of active
constituents responsible for this activity is described below.
Materials and Methods
General procedures
NMR spectra were recorded at 25 8C on a Varian Gemini 2000
or a Bruker AMX 400 spectrometer (proton frequency 300.07
and 400.13MHz, respectively), with CDCl
3
as solvent and TMS
as internal standard, using standard library pulse sequences.
NOESY spectra were obtained with mixing times of 500±
900ms. HMBC spectra were optimized for
n
J
CH
of 4±11Hz.
Mass spectra were obtained on a JEOL JMS-AX505W double
focussing spectrometer with EI or FAB ionization (positive ion
mode). Column chromatography was performed on silica gel
60 (Merck, 0.063±0.2mm). Fractions were monitored by TLC
(Merck precoated silica gel 60 F
254
plates), using UV light and
Dragendorff reagent to visualize the spots. Preparative HPLC
was carried out on a 250  16mm Knauer column packed
with LiChrospher-100 RP18, 5mm, using a Waters system con-
sisting of a model 590 pump and a model 481 UV spectropho-
tometer operating at 225 nm. Compounds 6±8 were obtained
from commercial sources, whereas 9 and 10 were synthetic,
racemic compounds (14); the identity and purity of all mate-
rials was confirmed by
1
H-NMR spectroscopy.
Plant material
C. pachyceras K. Schum. was identified and its bark collected
by Mr. D. K. Abbiw, Department of Botany, University of Ghana,
near Agriculture Research Station, Kede, South Ghana. A vouch-
er specimenwas deposited in Ghana Herbarium (GC 47529).
Extraction and isolation
Powdered stem bark (250 g) was macerated three times with
1 l of CH
2
Cl
2
-MeOH (1:1) to give a total of 47 g of raw extract.
The extract was partitioned between light petroleum, EtOAc
and H
2
O, and the fractions tested for antileishmanial and anti-
malarial activity. The activity was confined to the EtOAc frac-
tion, which was subjected to open column chromatography
(silica gel, stepwise gradient elution from CH
2
Cl
2
to EtOAc to
MeOH). The activity was present in alkaloid-containing frac-
tions (Dragendorff reagent). A portion (182mg) of the com-
bined alkaloid fraction (6.34 g) was subjected to preparative
HPLC (6ml/min of 70% MeOH in 0.01M aq. AcONH
4
, pH 8.04),
to give, in the order of elution, 16.6mg of 1, 2.1mg of 2,
10.3mg of 3, 6.3mg of 4, and 9.2mg of 5.
Corynanthine (1): Colorless oil; [a]20
D
: ±76.58 (c 0.38, pyridine),
lit. (2) ±738 (pyridine); HREIMS: m/z = 353.1875 ([M ± H]
+
),
C
21
H
25
N
2
O
3
requires 353.1865. Content in the bark 0.23%.
a-Yohimbine (2): Colorless oil; [a]20
D
: ±178 (c 1.38, pyridine),
lit. (3) ±188 (pyridine); HRFABMS: m/z = 355.2044 ([M + H]
+
),
C
21
H
27
N
2
O
3
requires 355.2022. Content in the bark 0.03%.
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Dihydrocorynantheine (3): Colorless oil; [a]20
D
: +258 (c 0.67,
MeOH), lit. (4) +36.28 (MeOH); HRFABMS: m/z = 369.2155 ([M
+ H]
+
), C
22
H
29
N
2
O
3
requires 369.2178. Content in the bark
0.15%.
Corynantheine (4): Colorless oil; [a]20
D
: +328 (c 1.10, MeOH), lit.
(5) +28.58 (MeOH); HRFABMS: m/z = 367.1973 ([M + H]
+
),
C
22
H
27
N
2
O
3
requires 367.2022. Content in the bark 0.09%.
Corynantheidine (5): Colorless oil; [a]20
D
: ±1818 (c 7.41, MeOH),
lit. (6) ±1718 (MeOH); HRFABMS: m/z = 369.2137 ([M + H]
+
),
C
22
H
29
N
2
O
3
requires 369.2178. Content in the bark 0.13%.
Assay for antiplasmodial activity
A modification of Desjardins© radioisotope method (7) for
measuring growth of a chloroquine sensitive strain of Plasmo-
dium falciparum (3D7) was adopted, using uptake of [
3
H]phe-
nylalanine as an index of growth. Thus, 50ml of the growth
medium (RPMI 1640 added 5% Albumax, 5.95 g/l of HEPES,
31ml/l of 7.5% sodium bicarbonate, and 500mg/l of glucose)
containing test substances added from a DMSO stock were
mixed with a suspension of parasitic erythrocytes (5% hema-
tocrit, 2±3% parasitemia) in 96-well microtiter plates. The
maximal final DMSO concentration was 0.5%. Each concentra-
tion of the test substance was tested in triplicate. The plates
were incubated at 37 8C for 24 hours before the addition of
[
3
H]phenylalanine. After an additional 24 hours incubation
period, the parasites were harvested and incorporation of ra-
dioactivity determined by liquid scintillation counting.
Assay for leishmanicidal activity
Promastigotes from a WHO reference vaccine strain of Leish-
mania major were maintained at 26 8C in RPMI 1640 medium
containing 25mM HEPES, 4mM L-glutamine, 0.02mg/ml of
gentamicin, and 10% of heat-inactivated fetal calf serum. The
effect of plant extract and pure compounds on the growth of
promastigotes was assessed by monitoring inhibition of
[
3
H]thymidine uptake similarly as previously described (8).
The compounds for testing were dissolved in DMSO, the stock
solution diluted appropriately with the growth medium, and
aliquots incubated in 96-well microtiter plates with promasti-
gotes (1  10
7
per ml, 180ml/well) for 2 hours. After addition
of [
3
H]thymidine the plates were incubated for 18 hours, the
cells harvested, and the incorporation of radioactivity deter-
mined by liquid scintillation counting.
Assay for cytostatic activity
Mycoplasma-free carcinoma cell lines KB-3-1 (a HeLa sub-
clone) and KB-V1, selected for resistance with vinblastine
from the KB-3-1 cells (9), were obtained from the Laboratory
of Cell Biology, National Cancer Institute, National Institutes
of Health, Bethesda, Maryland, USA. The cells were main-
tained in monolayers at 37 8C in an atmosphere containing 5%
CO
2
(humidity 98%), using Dulbecco©s modified Eagle medium
(DMEM) containing 10% fetal bovine serum, glucose (4.5 g/l),
L-glutamine (0.58 g/l), sodium pyruvate (1mM), penicillin
(100 units/ml) and streptomycin (100mg/ml). The KB-V1 cells
were grown in the absence of cytostatic pressure from vin-
blastine, but the cells from passage number 5-15 preserved
unchanged degree of resistance to rhodamine 123 (10), and
were used in the assay. For the cytotoxicity assays, the KB-3-1
cells (70±80% confluency) or the KB-V1 cells (60±70% con-
fluency) were harvested by trypsinization, applied into 96-
well plates (4  10
3
of KB-3-1 cells or 7  10
3
of KB-V1 cells
per well) in 75ml of the culture medium, and grown for 24
hours. Test substances were applied in 75ml of a solution pre-
pared by mixing 50ml of a DMSO stock with 0.950ml of the
medium and appropriately diluted with the medium to re-
quired concentrations; thus, no well contained more than
0.25% of DMSO, which was also present in the control wells.
Six wells were used for each concentration of the test sub-
stance. Time of incubation and the amounts of the cells used
were such that the cells in the control wells reached 70% (KB-
3-1) or 60±70% (KB-V1) confluency at the end of the 72 hours
incubation period. After the incubation the medium was re-
moved and the amount of cells was determined using the
CellTiter 96 aqueous cell proliferation assay kit from Promega
Corporation. The MTS/PMS reagent (11) was freshly prepared
by mixing 2.0ml MTS solution (2mg/ml) with 99.4ml PMS
solution (0.92mg/ml) and 10.4ml of growth medium (with-
out phenol red and serum). After addition of 120ml of the re-
agent mixture to each well, the plate was incubated for
50min and the absorbance determined at 490 nm. The re-
ported IC
50
values are the result of three separate determina-
tions with different passages of the cells.
Results and Discussion
Crude ethanolic extracts of C. pachyceras bark strongly inhibit-
ed growth of Plasmodium falciparum and of Leishmania major
promastigotes. Fractionation of the extract on silica gel
showed that the activity was confined to fractions which gave
a positive reaction with the Dragendorff reagent. Individual
constituents of the alkaloid fraction were separated by prepa-
rative, reversed-phase HPLC using a mixture of methanol and
ammonium acetate buffer. Optimization of the HPLC system
showed that the separation was improved with increasing pH,
and baseline separation was achieved at pH 8.04. Five indole
alkaloids were isolated in amounts corresponding to the total
alkaloid content in the plant material of 0.63%.
Compounds 1 and 2 (Fig.1) were isomers with the molecular
formula C
21
H
26
N
2
O
3
as determined by HRMS.
13
C-NMR spectra
indicated the presence of a yohimboid skeleton (12). Analy-
sis of coupling patterns, supported by COSY and NOESY ex-
periments, led to identification of the stereochemistry as
3a,15a,20b (normal configuration) for 1 and as 3a,15a,20a
(allo configuration) for 2. Furthermore, both compounds have
H-16 in the a-configuration and H-17 in the b-configuration.
The compounds 1 and 2 thus correspond to corynanthine and
a-yohimbine, respectively. Compounds 3 and 5 were isomers
with the molecular formula C
22
H
28
N
2
O
3
(HRMS).
13
C-NMR
spectra showed the presence of a corynantheine-type struc-
ture (13). The stereochemistry of the corynene skeleton in 5
was established as 3a,15a,20a; 5 is thus corynantheidine.
Compound 3 showed broadened resonances in the 400MHz
1
H-NMR spectrum, indicating the presence of several con-
formers in slow exchange on the NMR time scale, but the al-
kaloid could be unambiguously identified as dihydrocorynan-
theine by comparison of its
1
H- and
13
C-NMR spectra with
those of an original sample of synthetic (14), racemic dihydro-
corynantheine. Compound 4 was identified as an unsaturated
analogue of 3, corynantheine (13).
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The
13
C-NMR data for 1±5 (Fig.1) are given in Table 1. On the
basis of
1
H,
13
C chemical shift correlation experiments, the as-
signments of C-10 and C-11 in 3±5 were reversed as compar-
ed to the earlier reports (13), (15). The original literature as-
signments were apparently based on a previous (16), errone-
ous assignment of C-5 and C-6 in indole, which persisted in
the literature for a long time before being corrected (17), (18).
The assignments in Table 1 are based on HMQC experiments
and are in agreement with those recently published for syn-
thetic rac-5 (19). The fully assigned
1
H-NMR data for 1±5, not
reported previously, are shown in Table 2.
Pure indole alkaloids 1±5were tested in vitro for antileishma-
nial, antimalarial and cytotoxic activity. The results are shown
in Table 3. The leishmanicidal activity was assessed using
L. major promastigote cultures and compared with that of an-
timony (V) sodium gluconate (sodium stibogluconate, Pentos-
tam), which is the recommended drug for the treatment of
leishmaniasis, but is rather inactive in this in vitro test. The
antimalarial activity was assessed with a chloroquine-sensi-
tive strain of P. falciparum. Assay for cytotoxicity included
growth inhibition of two carcinoma cell lines, a drug sensitive
KB-3-1 cell line and a multidrug resistant KB-V1 cell line. The
KB-V1 cells display the complete multidrug-resistance pheno-
type including the expression of the P-170 glycoprotein (9),
(20), (21).
Since no previous reports about leishmanicidal activity of yo-
himbine- and corynantheine-type alkaloids exist, several
structurally related alkaloids were included in the test. These
include reserpine (6), ajmalicine (7), ajmaline (8), as well as
two synthetic, racemic compounds rac-9 and rac-10 (Fig. 2)
(14). The leishmanicidal activity of 3±5, 7, rac-9 and rac-10
corresponded to IC
50
values below 3mM (Table 3). Interesting-
ly, ajmaline (8) was inactive against L. major promastigotes,
suggesting that the active alkaloids should contain a relatively
planar tetracyclic structure.
The antimalarial activity exhibited by the compounds tested
was rather low (Table 3). The most active of the alkaloids test-
ed was reserpine (6). However, it should be noted that the
three alkaloids with the corynene skeleton 3±5 were signifi-
cantly more toxic to P. falciparum than the yohimbine-type al-
kaloids 1 and 2. The activity of rac-9 and rac-10was also high-
er than that of 1 and 2. There was no difference in the anti-
plasmodial activity of 3 and rac-3, showing that the eudismic
index for dihydrocorynantheine is close to unity. On the other
hand, a small difference in the IC
50
values for the leishmanici-
dal activity between 3 and rac-3 suggests that the natural,
dextrorotatory 3 is somewhat more potent than its enantio-
mer.
None of the alkaloids isolated from C. pachyceras exhibited
significant cytotoxicity (Table 3). This confirms that the leish-
manicidal activity exhibited by these alkaloids is not due to a
general antiproliferative effect. The toxicity of 1±5 to the
drug-sensitive KB-3-1 cells and the multidrug-resistant KB-
V1 cells was identical. The resistance of the KB-V1 cells rela-
tive to the KB-3-1 cells is 210-fold for vinblastine and even
Fig.1 Structures of indole alkaloids isolated from Corynanthe pa-
chyceras: 1, corynanthine; 2, a-yohimbine; 3, dihydrocorynantheine;
4, corynantheine; 5, corynantheidine.
Table 1
13
C-NMR data (CDCl
3
) for C. pachyceras alkaloids.
1 2 3 4 5
C-2 134.6 134.5 135.3 135.2 135.9
C-3 60.4 60.3 60.4 60.1 61.4
C-5 52.9 53.3 53.3 52.9 53.6
C-6 21.5 21.8 22.6 21.8 21.9
C-7 108.0 108.5 108.0 108.0 108.3
C-8 127.4 127.3 127.6 127.6 127.8
C-9 118.2 118.1 118.3 118.3 118.3
C-10 119.4 119.5 119.5 119.5 119.5
C-11 121.3 121.5 121.4 121.4 121.3
C-12 110.9 110.8 111.0 111.0 110.9
C-13 136.0 136.0 136.3 136.3 136.2
C-14 33.6 27.7 33.9 33.4 29.9
C-15 36.9 38.0 38.9 38.8 40.8
C-16 51.1 54.8 111.9 111.7 111.7
C-17 67.0 66.1 160.3 160.2 160.9
C-18 28.5 33.1 11.3 115.7 12.9
C-19 23.7 24.6 24.4 139.6 19.1
C-20 34.9 36.6 39.3 42.9 40.0
C-21 62.1 60.6 61.8 61.4 57.9
C-22 51.4 52.0 51.5 51.4 51.5
C-23 172.5 174.7
a
169.5 169.6
C-24 61.0 61.7 61.7
a
Not detectable due to exchange-broadening.
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higher for other cytotoxic drugs (9), (10). This indicates that
the Corynanthe alkaloids, unlike many other alkaloids includ-
ing Catharanthus alkaloids, are not substrates for the P-170 ef-
flux pump.
Since pentavalent antimony complexes are the only antileish-
manial agents with a clearly favorable therapeutic index,
there is a high interest in identification of alternative chemo-
therapeutic leads. The alkaloids identified in this work as an-
tileishmanial compounds with their IC
50
values of 1mM or be-
low (Table 3) belong to the most potent natural products
showing leishmanicidal activity in similar in vitro assays (22±
26). At present, there is no basis for a conclusion about
mechanism of the leishmanicidal effects of these alkaloids.
Table 2
1
H-NMR data (CDCl
3
) for C. pachyceras alkaloids (coupling constants given as numberic values in Hz).
1 2 3 4 5
H-1 7.87 7.73 7.99 7.87 7.79
H-3 3.26 3.15
a
3.29 3.18
3
J
3,14ax
= 11.6
3
J
3,14ax
= 12.6
3
J
3,14ax
= 10.5
3
J
3,14ax
= 11.3
H-5 2.58 (ax), 3.07 (eq) 2.51 (ax), 3.07 (eq)
a
2.61 (ax), 3.11 (eq) 2.58 (ax), 2.96 (eq)
2
J
5ax,5eq
=
3
J
5ax,6ax
= 10.9
3
J
5ax,6eq
= 5.2
H-6 3.00 (ax), 2.70 (eq) 2.92 (ax), 2.68 (eq)
a
3.04 (ax), 2.72 (eq) 2.95 (ax), 2.72 (eq)
2
J
6eq,6ax
= 15.0,
3
J
6eq,5ax
= 3.5,
3
J
6eq,5eq
= 1.5
H-9 7.48 7.46 7.45 7.46 7.46
3
J
9,10
= 7.8
3
J
9,10
= 7.6
3
J
9,10
= 7.1
3
J
9,10
= 7.1,
4
J
9,11
= 1.5
3
J
9,10
= 7.3,
4
J
9,11
= 1.5
H-10 7.09 7.08 7.00 7.07 7.06
3
J
10,11
= 7.8
3
J
10,11
= 1.6,
3
J
10,11
= 7.1,
3
J
10,11
= 7.1,
3
J
10,11
= 1.3,
4
J
10,12
= 1.2
4
J
10,12
= 1.4
4
J
10,12
= 1.5
4
J
10,12
= 1.5
H-11 7.18 7.13 7.11 7.11 7.11
3
J
11,12
= 7.8
3
J
11,12
= 7.6,
3
J
11,12
= 7.1,
3
J
11,12
= 7.1
3
J
11,12
= 7.3
4
J
11,9
= 1.2
4
J
11,9
= 1.4
H-12 7.36 7.30 7.29 7.26 7.29
H-14 1.42 (ax), 1.68 (eq) 1.71 (ax), 1.60 (eq)
a
2.11 (ax), 1.97 (eq) 2.52 (ax), 1.83 (eq)
3
J
15,14eq
= 11.6,
2
J
14ax,14eq
=
3
J
14ax,15
= 12.6,
2
J
14ax,14eq
=
3
J
14ax,15
= 12.1,
2
J
14eq,14ax
= 13.1,
3
J
14ax,15
= 3.8
3
J
14eq,3
=
3
J
14eq,15
= 3.8
3
J
14eq,3
=
3
J
14eq,15
= 3.4
3
J
14eq,3
=
3
J
14eq,15
= 2.5
H-15 1.88 2.44
a
2.77 3.05
3
J
15,20
= 11.6,
3
J
15,16
=
3
J
15,20
= 3.8
3
J
15,20
= 11.8
3
J
15,16
= 3.8
H-16 2.61 2.56 ± ± ±
3
J
16,17
= 10.5
H-17 4.19 4.00 7.37 7.33 7.43
3
J
17,16
=
3
J
17,18ax
3
J
17,18ax
= 11.0,
=
3
J
17,18eq
= 2.5
3
J
17,18eq
= 4.5
H-18 1.73 (ax), 2.12 (eq) 1.37 (ax), 2.06 (eq)
a
4.95 (H
E
), 5.04 (H
Z
) 0.95
2
J
18ax,18eq
=
3
J
18ax,19ax
= 13.5,
3
J
18E,19
= 10.3,
2
J
18E,18Z
=
3
J
18,19
= 7.0
3
J
18ax,19eq
= 4.0 2.0,
3
J
18Z,19
= 17.3,
4
J
18Z,20
= 0.7
H-19 1.43 (ax, eq) 2.10 (ax), 1.56 (eq)
a
5.58 1.76, 1.20
2
J
19ax,19eq
=
3
J
19ax,20
= 13.5,
3
J
19,20
= 8.2
3
J
19ax,18eq
=
3
J
19eq,18eq
=
3
J
19eq,20
= 4.0
H-20 2.04 1.82
a
3.07 1.63
3
J
20,19ax
=
3
J
20,21ax
= 11.6,
3
J
20,19eq
=
3
J
20,21eq
= 3.4
H-21 2.09 (ax), 2.95 (eq) 2.59 (ax), 2.85 (eq)
a
2.31 (ax), 3.05 (eq) 2.48 (ax), 3.02 (eq)
2
J
21ax,21eq
= 10.6
2
J
21ax,21eq
= 11.5,
3
J
21ax,20
=
2
J
21ax,21eq
=
3
J
21ax,20
= 12.8
2
J
21ax,21eq
= 11.0,
3.3,
3
J
21eq,20
= 2.1
3
J
21ax,20
= 2.0
H-22 3.56 3.84
a
3.69 3.71
H-24 ± ±
a
3.75 3.72
a
Not assigned due to exchange-broadening.
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However, it should be noted that ajmalicine (7) is an extreme-
ly potent inhibitor of the 2D6 subfamily of cytochrome P450
(27). Whether or not the observed high activity of 7 and the
isolated C. pachyceras alkaloids (Table 3) is related to an inhib-
ition of the respiratory chain of L. major has yet to be deter-
mined.
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